Hippo signaling: A hub of growth control, tumor suppression and pluripotency maintenance

Mengxin Yin,
Lei Zhang^,

State Key Laboratory of Cell Biology, Institute of Biochemistry and Cell Biology, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, 320 Yueyang Road, Shanghai 200031, China

More Information

Corresponding author: E-mail address: rayzhang@sibs.ac.cn (Lei Zhang)

摘要

- /
- /
- /
- /
- /
- /
Abstract: The molecular mechanisms of organ size control and regulation remain one of the major unsolved mysteries of development biology. Almost a decade ago, the discovery of the Hippo signaling pathway in Drosophila shed some light on this puzzling issue. The Hippo signaling pathway is highly conserved in both invertebrates and vertebrates, and plays critical roles in animal development. It controls organ size and growth by inhibiting cell proliferation and by promoting apoptosis. Malfunction of the Hippo signaling pathway leads to cancer development and tumorigenesis. Although the core of the signaling pathway is well understood, the upstream inputs and downstream transcriptional regulation are still obscure to us. In this review, we summarize the current understanding of the mechanism and the function of the Hippo signaling pathway and compare its differences between flies and mammals. We underline the crosstalk between the Hippo signaling pathway and other signaling pathways, and the possible roles of the Hippo pathway in stem cell proliferation and self-renewal.
- Cell signaling /
- Crosstalk /
- Development /
- Hippo /
- Organ size control /
- Stem cell /
- Tumorigenesis

HTML全文

参考文献(139)

[1]	Alarcon, C., Zaromytidou, A.I., Xi, Q. et al. Nuclear CDKs drive Smad transcriptional activation and turnover in BMP and TGF-β pathways Cell, 139 (2009),pp. 757-769
[2]	Angus, L., Moleirinho, S., Herron, L. et al. Willin/FRMD6 expression activates the Hippo signaling pathway kinases in mammals and antagonizes oncogenic YAP Oncogene (2011)
[3]	Asthagiri, A.R., Parry, D.M., Butman, J.A. et al. Neurofibromatosis type 2 Lancet, 373 (2009),pp. 1974-1986
[4]	Avruch, J., Xavier, R., Bardeesy, N. et al. Rassf family of tumor suppressor polypeptides J. Biol. Chem., 284 (2009),pp. 11001-11005
[5]	Badouel, C., Gardano, L., Amin, N. et al. Dev. Cell, 16 (2009),pp. 411-420
[6]	Baena-Lopez, L.A., Rodriguez, I., Baonza, A. Proc. Natl. Acad. Sci. USA, 105 (2008),pp. 9645-9650
[7]	Baumgartner, R., Poernbacher, I., Buser, N. et al. Dev. Cell, 18 (2010),pp. 309-316
[8]	Bazellieres, E., Assemat, E., Arsanto, J.P. et al. Crumbs proteins in epithelial morphogenesis Front. Biosci., 14 (2009),pp. 2149-2169
[9]	Bennett, F.C., Harvey, K.F. Curr. Biol., 16 (2006),pp. 2101-2110
[10]	Brittle, A.L., Repiso, A., Casal, J. et al. Four-jointed modulates growth and planar polarity by reducing the affinity of dachsous for fat Curr. Biol., 20 (2010),pp. 803-810
[11]	Brogiolo, W., Stocker, H., Ikeya, T. et al. Curr. Biol., 11 (2001),pp. 213-221
[12]	Cai, J., Zhang, N., Zheng, Y. et al. The Hippo signaling pathway restricts the oncogenic potential of an intestinal regeneration program Genes Dev., 24 (2010),pp. 2383-2388
[13]	Calamita, P., Fanto, M. Slimming down fat makes neuropathic Hippo: the Fat/Hippo tumor suppressor pathway protects adult neurons through regulation of autophagy Autophagy, 7 (2011),pp. 907-909
[14]	Callus, B.A., Verhagen, A.M., Vaux, D.L. FEBS J., 273 (2006),pp. 4264-4276
[15]	Casal, J., Lawrence, P.A., Struhl, G. Two separate molecular systems, Dachsous/Fat and Starry night/Frizzled, act independently to confer planar cell polarity Development, 133 (2006),pp. 4561-4572
[16]	Chan, E.H., Nousiainen, M., Chalamalasetty, R.B. et al. The Ste20-like kinase Mst2 activates the human large tumor suppressor kinase Lats1 Oncogene, 24 (2005),pp. 2076-2086
[17]	Chan, S.W., Lim, C.J., Loo, L.S. et al. TEADs mediate nuclear retention of TAZ to promote oncogenic transformation J. Biol. Chem., 284 (2009),pp. 14347-14358
[18]	Chan, S.W., Lim, C.J., Huang, C. et al. WW domain-mediated interaction with Wbp2 is important for the oncogenic property of TAZ Oncogene, 30 (2011),pp. 600-610
[19]	Chen, C.L., Gajewski, K.M., Hamaratoglu, F. et al. Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 15810-15815
[20]	Chen, H.I., Einbond, A., Kwak, S.J. et al. Characterization of the WW domain of human yes-associated protein and its polyproline-containing ligands J. Biol. Chem., 272 (1997),pp. 17070-17077
[21]	Cho, E., Feng, Y., Rauskolb, C. et al. Delineation of a Fat tumor suppressor pathway Nat. Genet., 38 (2006),pp. 1142-1150
[22]	Cinar, B., Fang, P.K., Lutchman, M. et al. The pro-apoptotic kinase Mst1 and its caspase cleavage products are direct inhibitors of Akt1 EMBO J., 26 (2007),pp. 4523-4534
[23]	Conlon, I., Raff, M. Size control in animal development Cell, 96 (1999),pp. 235-244
[24]	Das Thakur, M., Feng, Y., Jagannathan, R. et al. Ajuba LIM proteins are negative regulators of the Hippo signaling pathway Curr. Biol., 20 (2010),pp. 657-662
[25]	Dong, J., Feldmann, G., Huang, J. et al. Cell, 130 (2007),pp. 1120-1133
[26]	Dupont, S., Morsut, L., Aragona, M. et al. Role of YAP/TAZ in mechanotransduction Nature, 474 (2011),pp. 179-183
[27]	Feng, Y., Irvine, K.D. Fat and expanded act in parallel to regulate growth through warts Proc. Natl. Acad. Sci. USA, 104 (2007),pp. 20362-20367
[28]	Feng, Y., Irvine, K.D. Processing and phosphorylation of the Fat receptor Proc. Natl. Acad. Sci. USA, 106 (2009),pp. 11989-11994
[29]	Fernandez, B.G., Gaspar, P., Bras-Pereira, C. et al. Development, 138 (2011),pp. 2337-2346
[30]	Fernandez, L.A., Northcott, P.A., Dalton, J. et al. YAP1 is amplified and up-regulated in hedgehog-associated medulloblastomas and mediates Sonic hedgehog-driven neural precursor proliferation Genes Dev., 23 (2009),pp. 2729-2741
[31]	Genevet, A., Wehr, M.C., Brain, R. et al. Kibra is a regulator of the Salvador/Warts/Hippo signaling network Dev. Cell, 18 (2010),pp. 300-308
[32]	Gilbert, M.M., Tipping, M., Veraksa, A. et al. Dev. Cell, 20 (2011),pp. 700-712
[33]	Goulev, Y., Fauny, J.D., Gonzalez-Marti, B. et al. Curr. Biol., 18 (2008),pp. 435-441
[34]	Grusche, F.A., Richardson, H.E., Harvey, K.F. Upstream regulation of the Hippo size control pathway Curr. Biol., 20 (2010),pp. R574-582
[35]	Grzeschik, N.A., Parsons, L.M., Allott, M.L. et al. Lgl, aPKC, and Crumbs regulate the Salvador/Warts/Hippo pathway through two distinct mechanisms Curr. Biol., 20 (2010),pp. 573-581
[36]	Habbig, S., Bartram, M.P., Muller, R.U. et al. NPHP4, a cilia-associated protein, negatively regulates the Hippo pathway J. Cell Biol., 193 (2011),pp. 633-642
[37]	Halder, G., Johnson, R.L. Hippo signaling: growth control and beyond Development, 138 (2011),pp. 9-22
[38]	Harvey, K.F., Pfleger, C.M., Hariharan, I.K. Cell, 114 (2003),pp. 457-467
[39]	Hergovich, A., Schmitz, D., Hemmings, B.A. The human tumour suppressor LATS1 is activated by human MOB1 at the membrane Biochem. Biophys. Res. Commun., 345 (2006),pp. 50-58
[40]	Hesson, L.B., Dunwell, T.L., Cooper, W.N. et al. The novel RASSF6 and RASSF10 candidate tumour suppressor genes are frequently epigenetically inactivated in childhood leukaemias Mol. Cancer, 8 (2009),p. 42
[41]	Ho, K.C., Zhou, Z., She, Y.M. et al. Itch E3 ubiquitin ligase regulates large tumor suppressor 1 stability Proc. Natl. Acad. Sci. USA, 108 (2011),pp. 4870-4875
[42]	Hong, J.H., Hwang, E.S., McManus, M.T. et al. TAZ, a transcriptional modulator of mesenchymal stem cell differentiation Science, 309 (2005),pp. 1074-1078
[43]	Huang, J., Wu, S., Barrera, J. et al. Cell, 122 (2005),pp. 421-434
[44]	Ishikawa, H.O., Takeuchi, H., Haltiwanger, R.S. et al. Four-jointed is a Golgi kinase that phosphorylates a subset of cadherin domains Science, 321 (2008),pp. 401-404
[45]	Ishiuchi, T., Misaki, K., Yonemura, S. et al. Mammalian Fat and Dachsous cadherins regulate apical membrane organization in the embryonic cerebral cortex J. Cell. Biol., 185 (2009),pp. 959-967
[46]	Jia, J., Zhang, W., Wang, B. et al. Genes Dev., 17 (2003),pp. 2514-2519
[47]	Jiang, Z., Li, X., Hu, J. et al. Promoter hypermethylation-mediated down-regulation of LATS1 and LATS2 in human astrocytoma Neurosci. Res., 56 (2006),pp. 450-458
[48]	Justice, R.W., Zilian, O., Woods, D.F. et al. Genes Dev., 9 (1995),pp. 534-546
[49]	Kango-Singh, M., Nolo, R., Tao, C. et al. Development, 129 (2002),pp. 5719-5730
[50]	Karpowicz, P., Perez, J., Perrimon, N. The Hippo tumor suppressor pathway regulates intestinal stem cell regeneration Development, 137 (2010),pp. 4135-4145
[51]	Kim, N.G., Koh, E., Chen, X. et al. E-cadherin mediates contact inhibition of proliferation through Hippo signaling-pathway components Proc. Natl. Acad. Sci. USA, 108 (2011),pp. 11930-11935
[52]	Kosaka, Y., Mimori, K., Tanaka, F. et al. Int. J. Oncol., 31 (2007),pp. 333-338
[53]	Lai, Z.C., Wei, X., Shimizu, T. et al. Control of cell proliferation and apoptosis by mob as tumor suppressor, mats Cell, 120 (2005),pp. 675-685
[54]	Lee, K.P., Lee, J.H., Kim, T.S. et al. The Hippo-Salvador pathway restrains hepatic oval cell proliferation, liver size, and liver tumorigenesis Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 8248-8253
[55]	Lei, Q.Y., Zhang, H., Zhao, B. et al. TAZ promotes cell proliferation and epithelial-mesenchymal transition and is inhibited by the Hippo pathway Mol. Cell. Biol., 28 (2008),pp. 2426-2436
[56]	Levy, D., Adamovich, Y., Reuven, N. et al. Yap1 phosphorylation by c-Abl is a critical step in selective activation of proapoptotic genes in response to DNA damage Mol. Cell, 29 (2008),pp. 350-361
[57]	Lian, I., Kim, J., Okazawa, H. et al. The role of YAP transcription coactivator in regulating stem cell self-renewal and differentiation Genes Dev., 24 (2010),pp. 1106-1118
[58]	Ling, C., Zheng, Y., Yin, F. et al. The apical transmembrane protein Crumbs functions as a tumor suppressor that regulates Hippo signaling by binding to Expanded Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 10532-10537
[59]	Liu, C.Y., Lv, X., Li, T. et al. PP1 cooperates with ASPP2 to dephosphorylate and activate TAZ J. Biol. Chem., 286 (2011),pp. 5558-5566
[60]	Lu, L., Li, Y., Kim, S.M. et al. Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 1437-1442
[61]	Mao, Y., Kucuk, B., Irvine, K.D. Development, 136 (2009),pp. 3223-3233
[62]	Mao, Y., Rauskolb, C., Cho, E. et al. Development, 133 (2006),pp. 2539-2551
[63]	Mao, Y., Mulvaney, J., Zakaria, S. et al. Development, 138 (2011),pp. 947-957
[64]	Martin, D.E., Hall, M.N. The expanding TOR signaling network Curr. Opin. Cell Biol., 17 (2005),pp. 158-166
[65]	Matakatsu, H., Blair, S.S. The DHHC palmitoyltransferase approximated regulates Fat signaling and Dachs localization and activity Curr. Biol., 18 (2008),pp. 1390-1395
[66]	Minoo, P., Zlobec, I., Baker, K. et al. Prognostic significance of mammalian sterile20-like kinase 1 in colorectal cancer Mod. Pathol., 20 (2007),pp. 331-338
[67]	Murakami, M., Nakagawa, M., Olson, E.N. et al. A WW domain protein TAZ is a critical coactivator for TBX5, a transcription factor implicated in Holt-Oram syndrome Proc. Natl. Acad. Sci. USA, 102 (2005),pp. 18034-18039
[68]	Murakami, M., Tominaga, J., Makita, R. et al. Transcriptional activity of Pax3 is co-activated by TAZ Biochem. Biophys. Res. Commun., 339 (2006),pp. 533-539
[69]	Napoletano, F., Occhi, S., Calamita, P. et al. EMBO J., 30 (2011),pp. 945-958
[70]	Neto-Silva, R.M., de Beco, S., Johnston, L.A. Dev. Cell, 19 (2010),pp. 507-520
[71]	Oh, H., Irvine, K.D. Development, 135 (2008),pp. 1081-1088
[72]	Oh, H., Irvine, K.D. Oncogene, 28 (2009),pp. 1916-1927
[73]	Oh, H., Irvine, K.D. Cooperative regulation of growth by Yorkie and Mad through bantam Dev. Cell, 20 (2011),pp. 109-122
[74]	Ota, M., Sasaki, H. Mammalian Tead proteins regulate cell proliferation and contact inhibition as transcriptional mediators of Hippo signaling Development, 135 (2008),pp. 4059-4069
[75]	Oka, T., Schmitt, A.P., Sudol, M. Opposing roles of angiomotin-like-1 and zona occludens-2 on pro-apoptotic function of YAP Oncogene (2011)
[76]	Oka, T., Remue, E., Meerschaert, K. et al. Functional complexes between YAP2 and ZO-2 are PDZ domain-dependent, and regulate YAP2 nuclear localization and signalling Biochem. J., 432 (2010),pp. 461-472
[77]	Overholtzer, M., Zhang, J., Smolen, G.A. et al. Transforming properties of YAP, a candidate oncogene on the chromosome 11q22 amplicon Proc. Natl. Acad. Sci. USA, 103 (2006),pp. 12405-12410
[78]	Pan, D. The Hippo signaling pathway in development and cancer Dev. Cell, 19 (2010),pp. 491-505
[79]	Pantalacci, S., Tapon, N., Leopold, P. Nat. Cell Biol., 5 (2003),pp. 921-927
[80]	Park, K.S., Whitsett, J.A., Di Palma, T. et al. TAZ interacts with TTF-1 and regulates expression of surfactant protein-C J. Biol. Chem., 279 (2004),pp. 17384-17390
[81]	Peng, H.W., Slattery, M., Mann, R.S. Genes Dev., 23 (2009),pp. 2307-2319
[82]	Polesello, C., Huelsmann, S., Brown, N.H. et al. Curr. Biol., 16 (2006),pp. 2459-2465
[83]	Praskova, M., Xia, F., Avruch, J. MOBKL1A/MOBKL1B phosphorylation by MST1 and MST2 inhibits cell proliferation Curr. Biol., 18 (2008),pp. 311-321
[84]	Rauskolb, C., Pan, G., Reddy, B.V. et al. Zyxin links fat signaling to the Hippo pathway PLoS Biol., 9 (2011),p. e1000624
[85]	Ren, F., Zhang, L., Jiang, J. Hippo signaling regulates Yorkie nuclear localization and activity through 14-3-3 dependent and independent mechanisms Dev. Biol., 337 (2010),pp. 303-312
[86]	Renfranz, P.J., Siegrist, S.E., Stronach, B.E. et al. Gene, 305 (2003),pp. 13-26
[87]	Ribeiro, P.S., Josue, F., Wepf, A. et al. Combined functional genomic and proteomic approaches identify a PP2A complex as a negative regulator of Hippo signaling Mol. Cell, 39 (2010),pp. 521-534
[88]	Richardson, H.E. Actin up for Hippo EMBO J., 30 (2011),pp. 2307-2309
[89]	Richter, A.M., Pfeifer, G.P., Dammann, R.H. The RASSF proteins in cancer; from epigenetic silencing to functional characterization Biochim. Biophys. Acta, 1796 (2009),pp. 114-128
[90]	Robinson, B.S., Huang, J., Hong, Y. et al. Curr. Biol., 20 (2010),pp. 582-590
[91]	Rock, R., Schrauth, S., Gessler, M. Dev. Dyn., 234 (2005),pp. 747-755
[92]	Rogulja, D., Rauskolb, C., Irvine, K.D. Morphogen control of wing growth through the Fat signaling pathway Dev. Cell, 15 (2008),pp. 309-321
[93]	Saburi, S., Hester, I., Fischer, E. et al. Loss of Fat4 disrupts PCP signaling and oriented cell division and leads to cystic kidney disease Nat. Genet., 40 (2008),pp. 1010-1015
[94]	Salah, Z., Melino, G., Aqeilan, R.I. Negative regulation of the Hippo pathway by E3 ubiquitin ligase ITCH is sufficient to promote tumorigenicity Cancer Res., 71 (2011),pp. 2010-2020
[95]	Sansores-Garcia, L., Bossuyt, W., Wada, K. et al. Modulating F-actin organization induces organ growth by affecting the Hippo pathway EMBO J., 30 (2011),pp. 2325-2335
[96]	Sasaki, H., Kawano, O., Endo, K. et al. Human MOB1 expression in non-small-cell lung cancer Clin. Lung Cancer, 8 (2007),pp. 273-276
[97]	Scheel, H., Hofmann, K. A novel interaction motif, SARAH, connects three classes of tumor suppressor Curr. Biol., 13 (2003),pp. R899-R900
[98]	Schlegelmilch, K., Mohseni, M., Kirak, O. et al. Yap1 acts downstream of alpha-catenin to control epidermal proliferation Cell, 144 (2011),pp. 782-795
[99]	Seidel, C., Schagdarsurengin, U., Blumke, K. et al. Frequent hypermethylation of MST1 and MST2 in soft tissue sarcoma Mol. Carcinog., 46 (2007),pp. 865-871
[100]	Shaw, R.L., Kohlmaier, A., Polesello, C. et al. Development, 137 (2010),pp. 4147-4158
[101]	Silva, E., Tsatskis, Y., Gardano, L. et al. Curr. Biol., 16 (2006),pp. 2081-2089
[102]	Silvis, M.R., Kreger, B.T., Lien, W.H. et al. Alpha-catenin is a tumor suppressor that controls cell accumulation by regulating the localization and activity of the transcriptional coactivator Yap1 Sci. Signal., 4 (2011),p. ra33
[103]	Simon, M.A., Xu, A., Ishikawa, H.O. et al. Modulation of fat:dachsous binding by the cadherin domain kinase four-jointed Curr. Biol., 20 (2010),pp. 811-817
[104]	Song, H., Mak, K.K., Topol, L. et al. Mammalian Mst1 and Mst2 kinases play essential roles in organ size control and tumor suppression Proc. Natl. Acad. Sci. USA, 107 (2010),pp. 1431-1436
[105]	Sopko, R., Silva, E., Clayton, L. et al. Phosphorylation of the tumor suppressor fat is regulated by its ligand Dachsous and the kinase discs overgrown Curr. Biol., 19 (2009),pp. 1112-1117
[106]	Steinhardt, A.A., Gayyed, M.F., Klein, A.P. et al. Expression of Yes-associated protein in common solid tumors Hum. Pathol., 39 (2008),pp. 1582-1589
[107]	Strano, S., Munarriz, E., Rossi, M. et al. Physical interaction with Yes-associated protein enhances p73 transcriptional activity J. Biol. Chem., 276 (2001),pp. 15164-15173
[108]	Strano, S., Monti, O., Pediconi, N. et al. Mol. Cell, 18 (2005),pp. 447-459
[109]	Sun, G., Irvine, K.D. Regulation of Hippo signaling by Jun kinase signaling during compensatory cell proliferation and regeneration, and in neoplastic tumors Dev. Biol., 350 (2011),pp. 139-151
[110]	Takahashi, Y., Miyoshi, Y., Takahata, C. et al. Clin. Cancer Res., 11 (2005),pp. 1380-1385
[111]	Tapon, N., Harvey, K.F., Bell, D.W. et al. Cell, 110 (2002),pp. 467-478
[112]	Udan, R.S., Kango-Singh, M., Nolo, R. et al. Hippo promotes proliferation arrest and apoptosis in the Salvador/Warts pathway Nat. Cell Biol., 5 (2003),pp. 914-920
[113]	Varelas, X., Sakuma, R., Samavarchi-Tehrani, P. et al. TAZ controls Smad nucleocytoplasmic shuttling and regulates human embryonic stem-cell self-renewal Nat. Cell Biol., 10 (2008),pp. 837-848
[114]	Varelas, X., Samavarchi-Tehrani, P., Narimatsu, M. et al. The Crumbs complex couples cell density sensing to Hippo-dependent control of the TGF-β-SMAD pathway Dev. Cell, 19 (2010),pp. 831-844
[115]	Varelas, X., Miller, B.W., Sopko, R. et al. The Hippo pathway regulates Wnt/β-catenin signaling Dev. Cell, 18 (2010),pp. 579-591
[116]	Vigneron, A.M., Ludwig, R.L., Vousden, K.H. Cytoplasmic ASPP1 inhibits apoptosis through the control of YAP Genes Dev., 24 (2010),pp. 2430-2439
[117]	Wang, W., Huang, J., Chen, J. Angiomotin-like proteins associate with and negatively regulate YAP1 J. Biol. Chem., 286 (2011),pp. 4364-4370
[118]	Willecke, M., Hamaratoglu, F., Sansores-Garcia, L. et al. Boundaries of Dachsous Cadherin activity modulate the Hippo signaling pathway to induce cell proliferation Proc. Natl. Acad. Sci. USA, 105 (2008),pp. 14897-14902
[119]	Willecke, M., Hamaratoglu, F., Kango-Singh, M. et al. The fat cadherin acts through the hippo tumor-suppressor pathway to regulate tissue size Curr. Biol., 16 (2006),pp. 2090-2100
[120]	Wu, S., Huang, J., Dong, J. et al. Hippo encodes a Ste-20 family protein kinase that restricts cell proliferation and promotes apoptosis in conjunction with salvador and warts Cell, 114 (2003),pp. 445-456
[121]	Wu, S., Liu, Y., Zheng, Y. et al. The TEAD/TEF family protein Scalloped mediates transcriptional output of the Hippo growth-regulatory pathway Dev. Cell, 14 (2008),pp. 388-398
[122]	Xiao, L., Chen, Y., Ji, M. et al. J. Biol. Chem., 286 (2011),pp. 7788-7796
[123]	Xu, M.Z., Yao, T.J., Lee, N.P. et al. Yes-associated protein is an independent prognostic marker in hepatocellular carcinoma Cancer, 115 (2009),pp. 4576-4585
[124]	Xu, T., Wang, W., Zhang, S. et al. Development, 121 (1995),pp. 1053-1063
[125]	Yagi, R., Chen, L.F., Shigesada, K. et al. A WW domain-containing yes-associated protein (YAP) is a novel transcriptional co-activator EMBO J., 18 (1999),pp. 2551-2562
[126]	Yan, Y., Denef, N., Tang, C. et al. Development, 138 (2011),pp. 1697-1703
[127]	Yang, C.H., Axelrod, J.D., Simon, M.A. Cell, 108 (2002),pp. 675-688
[128]	Yu, J., Zheng, Y., Dong, J. et al. Kibra functions as a tumor suppressor protein that regulates Hippo signaling in conjunction with Merlin and Expanded Dev. Cell, 18 (2010),pp. 288-299
[129]	Zecca, M., Struhl, G. PLoS Biol., 8 (2010),p. e1000386
[130]	Zhang, H., Pasolli, H.A., Fuchs, E. Yes-associated protein (YAP) transcriptional coactivator functions in balancing growth and differentiation in skin Proc. Natl. Acad. Sci. USA, 108 (2011),pp. 2270-2275
[131]	Zhang, H., Liu, C.Y., Zha, Z.Y. et al. TEAD transcription factors mediate the function of TAZ in cell growth and epithelial-mesenchymal transition J. Biol. Chem., 284 (2009),pp. 13355-13362
[132]	Zhang, J., Ji, J.Y., Yu, M. et al. YAP-dependent induction of amphiregulin identifies a non-cell-autonomous component of the Hippo pathway Nat. Cell Biol., 11 (2009),pp. 1444-1450
[133]	Zhang, L., Yue, T., Jiang, J. Hippo signaling pathway and organ size control Fly (Austin), 3 (2009),pp. 68-73
[134]	Zhang, L., Ren, F., Zhang, Q. et al. The TEAD/TEF family of transcription factor Scalloped mediates Hippo signaling in organ size control Dev. Cell, 14 (2008),pp. 377-387
[135]	Zhao, B., Lei, Q.Y., Guan, K.L. The Hippo-YAP pathway: new connections between regulation of organ size and cancer Curr. Opin. Cell Biol., 20 (2008),pp. 638-646
[136]	Zhao, B., Ye, X., Yu, J. et al. TEAD mediates YAP-dependent gene induction and growth control Genes Dev., 22 (2008),pp. 1962-1971
[137]	Zhao, B., Li, L., Tumaneng, K. et al. A coordinated phosphorylation by Lats and CK1 regulates YAP stability through SCF(β-TRCP) Genes Dev., 24 (2010),pp. 72-85
[138]	Zhao, B., Li, L., Lu, Q. et al. Angiomotin is a novel Hippo pathway component that inhibits YAP oncoprotein Genes Dev., 25 (2011),pp. 51-63
[139]	Zhao, B., Wei, X., Li, W. et al. Inactivation of YAP oncoprotein by the Hippo pathway is involved in cell contact inhibition and tissue growth control Genes Dev., 21 (2007),pp. 2747-2761